Small Cell Sarcoma — Trials

Small Cell Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

54 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 22
Recruiting: 13
Ph III recruiting: 0
Growth YoY: —
Industry share: 5%
Top sponsor: Italian Sarcoma Group
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03600649	Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas	unknown	Phase 1	50	Salarius Pharmaceuticals, LLCINDUSTRY	1	Nov 21, 2023	clinicaltrials
NCT05266196	A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)	unknown	Phase 1 / Phase 2	10	Salarius Pharmaceuticals, LLCINDUSTRY	1	Aug 1, 2023	clinicaltrials